493 related articles for article (PubMed ID: 33957166)
41. Caffeic acid phenethyl ester inhibits pseudo-allergic reactions via inhibition of MRGPRX2/MrgprB2-dependent mast cell degranulation.
Adhikari N; Shim WS
Arch Pharm Res; 2022 Sep; 45(9):644-657. PubMed ID: 36183260
[TBL] [Abstract][Full Text] [Related]
42. Novel MRGPRX2 antagonists inhibit IgE-independent activation of human umbilical cord blood-derived mast cells.
Ogasawara H; Furuno M; Edamura K; Noguchi M
J Leukoc Biol; 2019 Nov; 106(5):1069-1077. PubMed ID: 31299111
[TBL] [Abstract][Full Text] [Related]
43. Inflamed Ulcerative Colitis Regions Associated With MRGPRX2-Mediated Mast Cell Degranulation and Cell Activation Modules, Defining a New Therapeutic Target.
Chen E; Chuang LS; Giri M; Villaverde N; Hsu NY; Sabic K; Joshowitz S; Gettler K; Nayar S; Chai Z; Alter IL; Chasteau CC; Korie UM; Dzedzik S; Thin TH; Jain A; Moscati A; Bongers G; Duerr RH; Silverberg MS; Brant SR; Rioux JD; Peter I; Schumm LP; Haritunians T; McGovern DP; Itan Y; Cho JH
Gastroenterology; 2021 Apr; 160(5):1709-1724. PubMed ID: 33421512
[TBL] [Abstract][Full Text] [Related]
44. A novel MRGPRX2-targeting antagonistic DNA aptamer inhibits histamine release and prevents mast cell-mediated anaphylaxis.
Suzuki Y; Liu S; Ogasawara T; Sawasaki T; Takasaki Y; Yorozuya T; Mogi M
Eur J Pharmacol; 2020 Jul; 878():173104. PubMed ID: 32320700
[TBL] [Abstract][Full Text] [Related]
45. Serum level of hemokinin-1 is significantly lower in patients with chronic spontaneous urticaria than in healthy subjects.
Nishimori N; Toyoshima S; Sasaki-Sakamoto T; Hayama K; Terui T; Okayama Y
Allergol Int; 2021 Oct; 70(4):480-488. PubMed ID: 34090787
[TBL] [Abstract][Full Text] [Related]
46. Activation of ryanodine-sensitive calcium store drives pseudo-allergic dermatitis
Wang Z; Zhao X; Zhou H; Che D; Du X; Ye D; Zeng W; Geng S
Front Immunol; 2023; 14():1207249. PubMed ID: 37404822
[TBL] [Abstract][Full Text] [Related]
47. Amelioration of Compound 48/80-Mediated Itch and LL-37-Induced Inflammation by a Single-Stranded Oligonucleotide.
Dondalska A; Rönnberg E; Ma H; Pålsson SA; Magnusdottir E; Gao T; Adam L; Lerner EA; Nilsson G; Lagerström M; Spetz AL
Front Immunol; 2020; 11():559589. PubMed ID: 33101278
[TBL] [Abstract][Full Text] [Related]
48. Upregulation of Mas-related G Protein coupled receptor X2 in asthmatic lung mast cells and its activation by the novel neuropeptide hemokinin-1.
Manorak W; Idahosa C; Gupta K; Roy S; Panettieri R; Ali H
Respir Res; 2018 Jan; 19(1):1. PubMed ID: 29295703
[TBL] [Abstract][Full Text] [Related]
49. Mast Cell-Specific MRGPRX2: a Key Modulator of Neuro-Immune Interaction in Allergic Diseases.
Thapaliya M; Chompunud Na Ayudhya C; Amponnawarat A; Roy S; Ali H
Curr Allergy Asthma Rep; 2021 Jan; 21(1):3. PubMed ID: 33398613
[TBL] [Abstract][Full Text] [Related]
50. MRGPRX2 is essential for sinomenine hydrochloride induced anaphylactoid reactions.
Liu R; Che D; Zhao T; Pundir P; Cao J; Lv Y; Wang J; Ma P; Fu J; Wang N; Wang X; Zhang T; Dong X; He L
Biochem Pharmacol; 2017 Dec; 146():214-223. PubMed ID: 28987593
[TBL] [Abstract][Full Text] [Related]
51. Inhibitory function of Shikonin on MRGPRX2-mediated pseudo-allergic reactions induced by the secretagogue.
Wang J; Zhang Y; Li C; Ding Y; Hu S; An H
Phytomedicine; 2020 Mar; 68():153149. PubMed ID: 32032836
[TBL] [Abstract][Full Text] [Related]
52. GRK2 differentially regulates FcεRI and MRGPRB2-mediated responses in mast cells.
Thapaliya M; Ali H
Front Immunol; 2023; 14():1155777. PubMed ID: 37063868
[TBL] [Abstract][Full Text] [Related]
53. Angiogenic Host Defense Peptide AG-30/5C and Bradykinin B
Roy S; Ganguly A; Haque M; Ali H
J Immunol; 2019 Feb; 202(4):1229-1238. PubMed ID: 30651343
[TBL] [Abstract][Full Text] [Related]
54. IL-33 and MRGPRX2-Triggered Activation of Human Skin Mast Cells-Elimination of Receptor Expression on Chronic Exposure, but Reinforced Degranulation on Acute Priming.
Wang Z; Guhl S; Franke K; Artuc M; Zuberbier T; Babina M
Cells; 2019 Apr; 8(4):. PubMed ID: 30979016
[TBL] [Abstract][Full Text] [Related]
55. Human Mast Cell Line HMC1 Expresses Functional Mas-Related G-Protein Coupled Receptor 2.
Hermans MAW; van Stigt AC; van de Meerendonk S; Schrijver B; van Daele PLA; van Hagen PM; van Splunter M; Dik WA
Front Immunol; 2021; 12():625284. PubMed ID: 33790895
[TBL] [Abstract][Full Text] [Related]
56. Antibody or Anybody? Considering the Role of MRGPRX2 in Acute Drug-Induced Anaphylaxis and as a Therapeutic Target.
Mackay GA; Fernandopulle NA; Ding J; McComish J; Soeding PF
Front Immunol; 2021; 12():688930. PubMed ID: 34867939
[TBL] [Abstract][Full Text] [Related]
57. Quercetin inhibits Mrgprx2-induced pseudo-allergic reaction via PLCγ-IP3R related Ca
Ding Y; Che D; Li C; Cao J; Wang J; Ma P; Zhao T; An H; Zhang T
Int Immunopharmacol; 2019 Jan; 66():185-197. PubMed ID: 30471617
[TBL] [Abstract][Full Text] [Related]
58. Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions.
McNeil BD; Pundir P; Meeker S; Han L; Undem BJ; Kulka M; Dong X
Nature; 2015 Mar; 519(7542):237-41. PubMed ID: 25517090
[TBL] [Abstract][Full Text] [Related]
59. MRGPRX2, drug pseudoallergies, inflammatory diseases, mechanisms and distinguishing MRGPRX2- and IgE/FcεRI-mediated events.
Baldo BA
Br J Clin Pharmacol; 2023 Nov; 89(11):3232-3246. PubMed ID: 37430437
[TBL] [Abstract][Full Text] [Related]
60. Substance P analogs devoid of key residues fail to activate human mast cells
Raj S; Hlushak S; Arizmendi N; Kovalenko A; Kulka M
Front Immunol; 2023; 14():1155740. PubMed ID: 37228611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
